High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
OBJECTIVE
We assessed the fibrinolytic activity of the organized mural thrombus lining of aneurysms and prosthetic grafts.


METHODS
Between May 1995 and April 1998, the full-thickness mural thrombi of aneurysms and the pseudointima lining of vascular grafts were obtained from 12 patients, ranging from 55 to 78 years in age, who underwent elective surgery. These included five aortic arch aneurysms, four abdominal aortic aneurysms, and three patent synthetic vascular grafts. The specimens were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)/immunoblot and immunohistochemistry for human plasmin/plasminogen, tissue plasminogen activator (tPA), and fibrin degradation product (D-dimer).


RESULTS
In the SDS-PAGE/immunoblot, 25- and 27-kd bands appeared specifically in experimental fibrin plates after limited digestion by plasmin and were also recognized in the mural thrombi. The presence of bands at 25 and 27 kd, which were most prominent in sections near the flow surface layer, was consistent with the hypothesis that the mural fibrin was digested by the endogenous plasmin. Apparent immunoreactivity was found at the flow surface of the masses at a thickness of 10 to 400 micrometer suggesting the presence of a plasminogen and tPA-rich layer, with D-dimer as a consequential product of fibrinolysis.


CONCLUSIONS
The hypothesis that fibrin surfaces in the arterial system acquire fibrinolytic activity because of digestion by circulating endogenous plasmin was confirmed; this may contribute to the antithrombogenicity of these flow surfaces.
First Department of Surgery, Asahikawa Medical College, and the R and D Center, the Terumo Corporation, Asahikawa, Japan.
T
T
Sasajima
Y
Y
Takano
Y
Y
Hiraishi
K
K
Goh
M
M
Inaba
N
N
Azuma
Y
Y
Sasajima
K
K
Yamazaki
H
H
Yamamoto
D000368:Aged; D000783:Aneurysm / Q000378:metabolism* / Q000473:pathology*; D001158:Arteries / Q000378:metabolism*; D001807:Blood Vessel Prosthesis; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005341:Fibrinolysin / Q000502:physiology; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010196:Pancreatic Elastase / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism*; D012039:Regional Blood Flow; D013927:Thrombosis / Q000378:metabolism* / Q000473:pathology*; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D005337:Fibrin; D010958:Plasminogen; D010196:Pancreatic Elastase; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin